ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signalling

This study reveals the regulatory mechanism of ECM1 in hepatocytes, demonstrating that EGF/STAT1 maintains ECM1 expression to prevent fibrosis, whereas IFNγ/NRF2 signalling inhibits ECM1 during chronic liver inflammation, thereby accelerating disease progression. These findings are important for researchers and clinicians to understand the pathogenesis of liver fibrosis, especially in CLD driven by inflammation or oxidative stress. Clinically, ECM1 levels correlate positively with EGFR expression and negatively with IFNγ/NRF2 activation, providing potential antifibrotic targets for CLD patients.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2025-04-11
DOI
https://doi.org/10.1016/j.jhepr.2025.101423
Primary Topic
Apelin-related biomedical research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signalling

Matthias Glanemann, Chenjun Huang, Shanshan Wang, Roman Liebe et al.
JHEP Reports
Apelin-related biomedical research
article

ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signalling

Matthias Glanemann, Chenjun Huang, Shanshan Wang, Roman Liebe, Cyrill Géraud, Matthias Ebert, Frederik Link, Chenhao Tong, Rilu Feng, Huiguo Ding, Peter ten Dijke, Zeribe C. Nwosu, Chunfang Gao, Weiguo Fan, Claudia Rubie, Steven Dooley, Christoph Meyer, Weronika Piorońska, Sai Wang, Lea Berger, Kerry Gould, Seddik Hammad, Yujia Li, Chen Shao, Yao Ye, Honglei Weng, Bing Sun, Laura Kim Feiner, Hui Liu, Pia Erdösi
article en

Abstract

This study reveals the regulatory mechanism of ECM1 in hepatocytes, demonstrating that EGF/STAT1 maintains ECM1 expression to prevent fibrosis, whereas IFNγ/NRF2 signalling inhibits ECM1 during chronic liver inflammation, thereby accelerating disease progression. These findings are important for researchers and clinicians to understand the pathogenesis of liver fibrosis, especially in CLD driven by inflammation or oxidative stress. Clinically, ECM1 levels correlate positively with EGFR expression and negatively with IFNγ/NRF2 activation, providing potential antifibrotic targets for CLD patients.

JHEP ReportsVol. 7(8)
Shanghai Jiao Tong University (CN), Capital Medical University (CN), Chinese Academy of Sciences (CN), Cornell University (US), Heidelberg University (DE), Leiden University Medical Center (NL), Renji Hospital (CN), University Hospital Heidelberg (DE), Shanghai University of Traditional Chinese Medicine (CN), Oncode Institute (NL), Essen University Hospital (DE), Center for Excellence in Molecular Cell Science (CN), Yueyang Hospital (CN), European Molecular Biology Laboratory (DE), Beijing YouAn Hospital (CN), University Medical Centre Mannheim (DE), Saarland University (DE)
Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung
Good health and well-being
Openalex Percentile: Top 91%
Apelin-related biomedical research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.